Injectable GLP-1 medications currently have a stronger and more established evidence base for weight loss, but oral options are showing meaningful results in clinical trials: In the head-to-head SURMOUNT-5 trial, researchers reported injectable tirzepatide had a mean weight reduction of about 20.2% at 72 weeks, compared with roughly 13.7% for injectable semaglutide
OCTN2 substrate niacin
Anhedonia is defined as a reduced interest or pleasure in activities that were once enjoyable
Mental health considerations: Some reports have noted changes in mood, including anxiety and, rarely, suicidal ideation
A wide variety of antioxidants are utilized clinically, either alone or in combination, with the goal of improving sperm quality and reproductive outcomes [42]
Some, such as semaglutide and tirzepatide, are now commonly prescribed for weight management